It is likely to precede other pathological hallmarks, such as amyloid-beta plaque deposition, and significantly affect the entire process of AD-related neuropathological changes, including neuronal glucose hypometabolism, tau aggregation, microglial activation, and neurodegeneration through the production of GABA and H2O2. Here, MAPT is linked to Alzheimer disease.